SEC Form 4 · accession 0001209191-17-036121
CRESCENT BIOPHARMA, INC. · CBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy R Pearson
Director
Period of report
May 25, 2017
Accepted (ET)
May 30, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253689
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $13.89 | May 25, 2017 | A | 11,000 | A | — | May 24, 2027 | Common Stock | 11,000 | 11,000 | D |
Explanation of responses
- F1The shares underlying this option vest on May 25, 2018, subject to the reporting person's continuous service as of such vesting date.